2025-03-31-accounts

Registered number: 01723353 Charity number: 326374

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

UNAUDITED

REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

CONTENTS

	Page
Reference and administrative details of the Society, its Council members and	1
advisers
Council members' report	2 - 7
Independent examiner's report	8 - 9
Statement of financial activities	10
Balance sheet	11 - 12
Notes to the financial statements	13 - 22

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE SOCIETY, ITS COUNCIL MEMBERS AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2025

Council members	Dr D Roberts, President
	Dr G D Poole (resigned 18 September 2024)
	Mrs C E George
	Dr I Sullivan
	Mr R C Haggas, Treasurer
	Miss J Staves
	Mrs R Braund
	Dr N Osaro
	Mr D Gaskin Dr K I Mead (appointed 28 November 2024)
Company registered number 01723353 Charity registered number 326374 Registered office C/O Armstrong Watson 1st Floor One Strawberry Lane Newcastle Upon Tyne NE1 4BX BBTS Executive Manager David Noble Accountants Armstrong Watson LLP Chartered Accountants First Floor One Strawberry Lane Newcastle Upon Tyne NE1 4BX Solicitors Hay & Kilner LLP The Lumen St James' Boulevard Newcastle Helix Newcastle upon Tyne NE4 5BZ

Page 1

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

COUNCIL MEMBERS' REPORT FOR THE YEAR ENDED 31 MARCH 2025

The Council members present their annual report together with the financial statements of the The British Blood Transfusion Society for the 1 April 2024 to 31 March 2025. The report serves the purposes of both a Council members' report and a directors' report under company law.

The Council members confirm that the report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Structure, governance and management

a. Governing document

The British Blood Transfusion Society was established in May 1983 as a company limited by guarantee governed by its Memorandum and Articles of Association (revised September 2011). It is registered as a charity with the Charity Commission. Every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up while he is a member or within one year after they cease to be a member.

b. Appointment of Council members

The Council members consist of officers, elected members and Past President or President Elect. Officers consist of the President of the Society who holds office for two years and the Secretary and Treasurer who hold office for three years. The President can remain as a Council member for a further year after retirement from the office of President. The Secretary and Treasurer are eligible for reappointment by Council, but neither can serve more than six consecutive years in office.

The elected Council members shall be those members of the Council who are not officers and shall each hold office for a period of three years; so far as possible they shall be made up of a mix of professional categories and be representative of the current membership; the period of office may be extended from time to time by the President for a year with a maximum of three extensions providing a maximum term of six years.

The Council members of the charitable company (excluding co-opted members) are its directors for the purposes of company law and trustees for the purposes of charity law. The elected Council members hold office for a period of three years.

Calls for nominations for officers and elected members of Council are made in the BBTS Bloodlines Newsletter and also on the Society’s website. Nominees must be UK members and must have been a member of the Society for a minimum of two years. Nominations must be proposed and seconded by two Society members. Details of the nominees are then published on the ballot papers.

c. Induction and training of Council members

All new Council members are given an induction pack containing information, links and paperwork about the roles and responsibilities of trustees published by the Charity Commission. They also receive past Council meeting papers and dates of forthcoming Council meetings.

At the first meeting of the new Council, new members are introduced to individual Council members and specific areas of responsibility for new members are discussed and agreed. The Society’s office then provides all the necessary background information and paperwork for new Council members’ individual areas of responsibility.

Page 2

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

COUNCIL MEMBERS' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Structure, governance and management (continued)

d. Organisation

The Society is managed by the Council members, who are responsible for the strategic direction and overview of the work of the Society. The Council members must number at least eight and not more than fourteen, all of whom must be members of the Society. Three Council members (including at least one officer) are needed for a quorum.

There are committees and sub-committees of Council members that may co-opt members who are not members of the Council or Society. Co-opted members may not exceed three-quarters of the total number of such committees. These committees include the Executive Working Committee, the Scientific Meetings Administration Committee, the Communications Committee and the Professional Affairs & Education Committee.

The day to day operations of the charity are managed by the BBTS Executive Manager and a small team of staff from an office based in Manchester.

e. BBTS Enterprises Limited

The charity’s wholly-owned subsidiary was incorporated in May 2003 and carries out trading activities for the charity. The subsidiary gift aids profits to the charity, subject to the retention of reserves for its own working capital requirements.

f. Risk management

The members of the Council are responsible for overseeing the risks faced by the Society. Within this process, detailed consideration of risks is delegated to the Executive Manager. Risks are identified, assessed and controls established throughout the year. Risks are held in a risk register. Council conducts ongoing reviews of the major risks to which the Society is exposed.

Page 3

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

COUNCIL MEMBERS' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Objectives, activities and performance

a. Objectives and activities

The main aim of the Society is to advance for the public benefit, the study of blood transfusion including immunohaematology and to promote research and development into all aspects of blood transfusion practice.

The objectives of the Society continue to be to:

• Provide education and training, including professional development

• Provide a forum for discussion and communication and facilitate the exchange of ideas between all

• groups through scientific meetings, special interest groups (SIGs) and the website

• Foster links with relevant national societies and organisations and ensure Society representation as

• appropriate

• Encourage research and development and disseminate information on new developments

• Contribute to the production of professional guidelines and promote best practice in all aspects of

• transfusion medicine

• Ensure recognition as the professional body for transfusion medicine by the government, health services

• and the public

• Contribute to the advancement of knowledge and services in developing countries

The Council sets itself annual objectives, in furtherance of the above main objectives of the Society. Each objective has a performance measure and responsibility is allocated to a Council member or Council subcommittee. Performance against the annual objectives is reviewed at Council meetings throughout the year and a progress report published in the Annual Review for members to view.

The Council confirm that they have been given the general guidance produced by the Charity Commission on public benefit including the guidance ‘public benefit running a charity (PB2)’. The Council are confident that public benefit is achieved through the study of blood transfusion and development.

b. Achievements and performance

The Society’s charitable activities focus on the study of blood transfusion and are undertaken to further its charitable purposes for the public benefit as described in the following paragraphs:

• The Society delivered its annual conference event in September 2024. The conference was held at

• Glasgow SEC. The Society met its AGM obligations to members on time.

• The Society continued to protect its finances during the year and worked hard for members to ensure it can continue and expand on its works and activities in the years ahead.

• The education programmes continue to provide valuable education and training opportunities and set out transfusion best practice. 150 people took an examination with an overall 87% pass rate and 80 text books were separately purchased. Our VLE software continues to be upgraded. The Moodle exam platform software, including online marking, was upgraded and continues to perform well.

• The CPD scheme provides a specific framework for transfusion professionals. This year the Society had 510 members who were both registered and active on the scheme. CPD News continues to provide members relevant opportunities to learn and reflect. The Society continues to improve its online CPD tool for members to populate and submit returns electronically.

• Through engagement with all members at every step the Society has continued to work closely with its Equality, Diversity and Inclusion Committee establishing further updated Terms of Reference.

Page 4

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

COUNCIL MEMBERS' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Objectives, activities and performance (continued)

(continued)

• Successfully delivering six editions of the Society’s Transfusion Medicine journal and four editions of its membership magazine Bloodlines.

• The Society has continued its representations as a professional body working towards the delivery of safe and effective transfusion practice.

During the year, Council achieved many of its major objectives including the improvement of our online course delivery and online exams, maintaining a strong Transfusion Medicine impact factor and gaining a respectable financial return from this journal.

The Society continues to work hard to rewrite and add to its CTP course content. We are planning to relaunch the course in 2026. We provided three educational webinars. The Transfusion Practitioners group has officially been made a Special Interest Group with the Chair being appointed to Council. We continued to mitigate financial risk to the Society during this period whilst remaining almost entirely financially independent.

Membership of the Society has changed during the year as follows:

Number of members on 1 April 2024	1,506
Number of new members	151
Number of members who left	(170)
Number of members on 31 March 2025	1,487

Financial review

a. Results

The principal funding sources of the Society are from training income and membership subscriptions. Income from these sources is shown in note 5 to the financial statements.

The net movement in funds for the year was a deficit of £40,195 (2024: £5,459), as shown in the statement of financial activities. There was a gift aid donation of £nil (2024: £4,390) from the subsidiary this year, so the operational deficit was £40,195 (2024: £9,849). The group deficit for the year was £50,381 (2024: £11,085).

b. Reserves policy

Council has established a policy whereby the unrestricted funds not committed, designated or invested in tangible fixed assets (the free reserves) held by the group should equate to at least £400,000. The reserves are needed to meet the ongoing working capital requirements of the group, to bridge any funding gaps during the development of new activities and to enable the group to continue its current activities in the event of a significant drop in income.

The free reserves of the charity as at 31 March 2025 were £356,654 (2024: £398,652) and those of the trading subsidiary add a further £78,794 (2024 £88,979), a total of £435,448 (2024: £487,631).

Page 5

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

COUNCIL MEMBERS' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

c. Investment powers and policy

Under the Memorandum and Articles of Association, the Society has the power to make investments as the Council members see fit.

Having regard to the Society’s liquidity requirements and reserves policy, Council have, in recent years, operated a policyof keeping available funds in interest-bearing deposit accounts.

d. Going concern

After making appropriate enquiries, the Council members have a reasonable expectation that the Society has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.

Plans for future periods

The Council has set itself a number of annual objectives for 2025/26, in furtherance of the main objectives of the Society. These objectives include the following:

• building on the strategies for membership expansion;

• a written update of its Transfusion Science Practice coursebook;

• relaunch of its Clinical Transfusion Practice course;

• to continue the successful delivery of online webinars;

• continually enhance our online exams to improve delivery and marking;

• bring our SiGs and their goals closer to the day to day work of Council;

• continue to re-enforce our relationships with other professional bodies;

• launch a new membership grade for lower band transfusion workers;

• launch the newly formed Early Career Professionals committee;

• launch the new BBTS website and a BBTS mobile app;

• continue to ensure its finances are adequate following a withdrawal of funding;

• • review alterative conference venues to protect our finances and reserves

Page 6

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

COUNCIL MEMBERS' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Statement of Council members' responsibilities

The Council members (who are also the directors of the Society for the purposes of company law) are responsible for preparing the Council members' report including the Strategic report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Council members to prepare financial statements for each financial . Under company law, the Council members must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Society and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Council members are required to:

• select suitable accounting policies and then apply them consistently;

• observe the methods and principles of the Charities SORP (FRS 102);

• make judgments and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Society will continue in business.

The Council members are responsible for keeping adequate accounting records that are sufficient to show and explain the Society's transactions and disclose with reasonable accuracy at any time the financial position of the Society and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Council members and signed on their behalf by:

PROF DAVID ROBERTS

PROF DAVID ROBERTS (Dec 1, 2025 11:47:41 GMT) ~~Dr D Roberts~~

Date:3 October 2025

Page 7

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 MARCH 2025

Independent examiner's report to the Council members of The British Blood Transfusion Society ('the Society')

I report to the charity Council members on my examination of the accounts of the Society for the year ended 31 March 2025.

Responsibilities and basis of report

As the Council members of the Society (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Society are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Society's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

Since the Society's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of (enter body here), which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Society as required by section 386 of the 2006 Act; or

2. the accounts do not accord with those records; or

3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

This report is made solely to the Society's Council members, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Society's Council members those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Society and the Society's Council members as a body, for my work or for this report.

Signed: D R Gold D R Gold (Dec 3, 2025 08:38:15 GMT) D R Gold BA FCA

Dated: 23 October 2025

Independent Examiner

Armstrong Watson LLP One Strawberry Lane

Page 8

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Newcastle upon Tyne NE1 4BX

Page 9

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2025

Note Income from: Donations 3 Investments 4 Charitable activities 5 Total income Expenditure on: Charitable activities 7 Total expenditure Net (expenditure) income and movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward	Unrestricted funds 2025 £ 215 14,099 261,852 276,166 316,361 316,361 (40,195) 444,663 (40,195) 404,468	Restricted funds 2025 £ 14,000 - - 14,000 14,000 14,000 - - - -	Total funds 2025 £ 14,215 14,099 261,852 290,166 330,361 330,361 (40,195) 444,663 (40,195) 404,468	Total funds 2024 £ 28,568 13,337 257,776 299,681 305,140 305,140 (5,459) 450,122 (5,459) 444,663

The Statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 13 to 22 form part of these financial statements.

Page 10

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) REGISTERED NUMBER: 01723353

BALANCE SHEET AS AT 31 MARCH 2025

Note Fixed assets Intangible assets 10 Tangible assets 11 Investments 12 Current assets Debtors 13 Cash at bank and in hand Creditors: amounts falling due within one year 14 Net current assets Total assets less current liabilities Capital grant Net assets Total net assets	183,893 312,469 496,362 (133,376)	2025 £ 44,956 2,857 1 47,814 362,986 410,800 (6,332) 404,468 404,468	137,115 391,329 528,444 (123,460)	2024 £ 44,956 1,054 1 46,011 404,984 450,995 (6,332) 444,663 444,663

Page 11

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee) REGISTERED NUMBER: 01723353

BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2025

Note Charity funds Restricted funds 15 Unrestricted funds 15 Total funds	2025 £ - 404,468 404,468	2024 £ - 444,663
		444,663

The Society was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Council members acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Council members and signed on their behalf by:

PROF DAVID ROBERTS

PROF DAVID ROBERTS (Dec 1, 2025 11:47:41 GMT) Dr D Roberts (Chair of Trustees) Date: 3 October 2025

R Haggas R Haggas (Nov 29, 2025 17:05:53 GMT) Mr R C Haggas

The notes on pages 13 to 22 form part of these financial statements.

Page 12

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

1. General information

The Society is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The financial statements are prepared in sterling which is the functional and presentation currency of the charity.

The British Blood Transfusion Society meets the definition of a public benefit entity under FRS 102.

Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Income

All income is included in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to particular categories of income:

Donations are received by way of grants and donations and are included in full in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Income from charitable activities includes income from membership subscriptions and training and is recognised in the period in which the Society is entitled to receipt. Deferred income represents amounts received for future periods and is released to the statement of financial activities for the period for which it has been released.

2.3 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity.

Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Society's objectives, as well as any associated support costs.

Page 13

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

2. Accounting policies (continued)

2.3 Expenditure (continued)

All expenditure is inclusive of irrecoverable VAT.

2.4 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Society; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.5 Intangible assets and amortisation

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Amortisation is provided on intangible assets at rates calculated to write off the cost of each asset on a straight-line basis over its expected useful life.

The estimated useful lives are as follows:

Website costs - 5 years

2.6 Tangible fixed assets and depreciation

Tangible fixed assets are included in the financial statements at their historical cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, .

Depreciation is provided on the following basis:

Fixtures and fittings - 20% On straight line basis Computer equipment - 25% On straight line basis

2.7 Investments

The investment in the subsidiary undertaking is included in the financial statements at cost. The financial statements for the Society include only the indivdual parent charity and are not consolidated to include the trading subsidiary. The parent charity is not required to prepare consolidated financial statements under section 399 of the Companies Act 2006 and is excepted by section 139(2) of the Charities Act 2011 from the requirement to prepare group accounts.

2.8 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.9 Cash at bank and in hand

Cash at bank includes a current account and an instant access COIF Charities Deposit Fund account.

Page 14

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

2. Accounting policies (continued)

2.10 Liabilities

Liabilities and provisions are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Society anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

2.11 Financial instruments

The Society only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

2.12 Fund structure

General funds are unrestricted funds which are available for use at the discretion of the Council members in furtherance of the general objectives of the Society and which have not been designated for other purposes. The general fund is credited with subscriptions received from members and income from training courses and associated income. It is charged with the charitable expenditure and governance costs of the Society.

Designated funds comprise unrestricted funds that have been set aside by the Council members for particular purposes. The aim and use of any designated fund is set out in the notes to the financial statements.

Grants obtained for specific purposes are recognised in the financial statements as restricted funds.

Investment income, gains and losses are allocated to the appropriate fund.

2.13 Judgements and key sources of estimation uncertainty

In applying the Society's accounting policies, the Council members are required to make judgements, estimates and assumptions in determining the carrying amounts of assets and liabilities. The Council members' judgements, estimates and assumptions are based on the best and most reliable evidence available at the time when the decisions are made, and are based on historical experience and other factors that are considered to be applicable.

Due to the inherent subjectivity involved in making such judgements, estimates and assumptions, the actual results and outcomes may differ. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the revision affects both current and future periods

Page 15

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

3. Income from donations

Donations Grants Donations Grants 4. Investment income Bank interest 5. Charitable activities Membership subscriptions Training	Unrestricted funds 2025 £ 215 - 215 Unrestricted funds 2024 £ 4,568 - 4,568 Unrestricted funds 2025 £ 14,099 Unrestricted funds 2025 £ 119,621 142,231 261,852	Restricted funds 2025 £ - 14,000 14,000 Restricted funds 2024 £ - 24,000 24,000 Total funds 2025 £ 14,099 Total funds 2025 £ 119,621 142,231 261,852	Total funds 2025 £ 215 14,000 14,215
			Total funds 2024 £ 4,568 24,000 28,568
			Total funds 2024 £ 13,337
			Total funds 2024 £ 116,532 141,244 257,776

Page 16

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

6. Independent examiner's remuneration

	2025	2024
	£	£
Fees payable to the Society's independent examiner for the independent
examination of the Society's annual accounts	1,320	1,228
Fees payable to the Society's independent examiner in respect of:
All other services not included above	8,418	8,833

7. Total resources expended

	Charitable	Governance	Total	Total
	activities	costs	2025	2024
	£	£	£	£
Direct costs Publicity and publications Bursaries and awards	2,722 -	- -	2,722 -	7,355 932
Educational programme	110,974	-	110,974	83,392
Modernising Scientific Careers	24,121	-	24,121	23,562
Allocated support costs
Staff costs	99,914	17,632	117,546	124,964
Office costs	44,707	19,161	63,868	54,570
Depreciation	603	258	861	916
Accountancy fees	4,501	4,501	9,002	8,652
Legal and other professional fees	887 288,429	380 41,932	1,267 330,361	797 305,140

8. Staff costs and numbers

	2025	2024
	£	£
Wages and salaries	162,765	158,991
National insurance costs	8,149	10,724
Pension costs	11,725	8,797
	182,639	178,512
Average number of employees in the year	5	5
(all management and administrative)

Page 17

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

9. Council members' remuneration and expenses

During the year, no Council members received any remuneration or other benefits (2024 - £NIL) .

During the year ended 31 March 2025, expenses totalling £ 2,386 were reimbursed or paid directly to 6 Council members (2024 - £761 to 4 Council members) .

10. Intangible assets

Cost At 1 April 2024 At 31 March 2025 Net book value At 31 March 2025 At 31 March 2024	Website £ 44,956 44,956 44,956
	44,956

Page 18

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

11. Tangible fixed assets

Cost or valuation At 1 April 2024 Additions At 31 March 2025 Depreciation At 1 April 2024 Charge for the year At 31 March 2025 Net book value At 31 March 2025 At 31 March 2024 12. Fixed asset investments Cost or valuation At 1 April 2024 At 31 March 2025 Net book value At 31 March 2025 At 31 March 2024	Fixtures and fittings £ 9,122 - 9,122 9,122 - 9,122 - -	Computer equipment £ 6,930 2,666 9,596 5,876 863 6,739 2,857 1,054	Total £ 16,052 2,666 18,718 14,998 863 15,861 2,857
			1,054
			Investments in subsidiary companies £ 1 1
			1 1

Page 19

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

13. Debtors

Due within one year Trade debtors Amounts due from subsidiary undertakings Prepayments and accrued income	2025 £ 10,702 144,613 28,578 183,893	2024 £ 42,550 87,073 7,492
		137,115

14. Creditors: Amounts falling due within one year

Trade creditors Other taxation and social security Other creditors Accruals and deferred income Deferred income at 1 April 2024 Resources deferred during the year Amounts released from previous periods	2025 £ 10,304 5,846 6,781 110,445 133,376 2025 £ 104,263 100,075 (104,263) 100,075	2024 £ 3,624 3,650 1,441 114,745
		123,460
		2024 £ 136,430 104,263 (136,430)
		104,263

Page 20

THE BRITISH BLOOD TRANSFUSION SOCIETY

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

15. Statement of funds

Statement of funds - current year

						Balance at
	Balance at		1			31 March
	April	2024		Income	Expenditure 2025
			£	£	£ £
Unrestricted funds
General funds	444,663			276,166	(316,361) 404,468
Restricted funds
Restricted funds		-		14,000	(14,000) -
Total of funds	444,663			290,166	(330,361) 404,468
Analysis of net assets between funds
Analysis of net assets between funds - current year
					Unrestricted Total
					funds funds
					2025 2025
					£ £
Tangible fixed assets					2,857 2,857
Intangible fixed assets					44,956	44,956
Fixed asset investments					1 1
Current assets					496,362 496,362
Creditors due within	one year				(133,376) (133,376)
Capital grant					(6,332) (6,332)
Total					404,468 404,468

16. Analysis of net assets between funds Analysis of net assets between funds - current year

Page 21

THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

16. Analysis of net assets between funds (continued)

Analysis of net assets between funds - prior year

Tangible fixed assets Intangible fixed assets Fixed asset investments Current assets Creditors due within one year Capital grant Total	Unrestricted funds 2024 £ 1,054 44,956 1 528,444 (123,460) (6,332) 444,663	Total funds 2024 £ 1,054 44,956 1 528,444 (123,460) (6,332) 444,663

17. Principal subsidiaries

The following was a subsidiary undertaking of the Society:

Name	Company	Pincipal place of business	Pincipal place of business	Class of	Holding
	number			shares
BBTS Enterprises Limited	4775642	England		Ordinary	100%
The financial results of the	subsidiary for the	year were:
Name		Income	Expenditure	Deficit for	Net assets
		£	£	the year	£
				£
BBTS Enterprises Limited		435,593	445,779	(10,186)	88,795

Page 22

The British Blood Transfusion Society Unit 22 Enterprise House Manchester Science Park Lloyd Street North Manchester M15 6SE

Date: 3 October 2025 Please ask for: David Gold Our Ref: 2590/49(20256/L) Your Ref: T: 0191 434 0830 e: [e-mail]

Dear Sirs

During the course of the preparation of and independent examination of your accounts for the period ending 31 March 2025, the following representations were made to us by the management and Council members. Please read these representations carefully and if you agree with our understanding please sign and return a copy of this letter to ourselves as confirmation of this.

Financial Statements

• 1 You have fulfilled your responsibility as trustees and directors, as set out in the terms of our engagement letter dated 11 September 2024, under the Charities Act 2011 and the Companies Act 2006 for preparing financial statements in accordance with the Companies Act 2006 and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which we have drafted on your behalf, which give a true and fair view of the financial position of the company as of 31 March 2025 and of the results of its operations for the year then ended and for making accurate representations to us.

• 2 Significant assumptions used by you in making accounting estimates, including those measured at fair value, are reasonable.

• 3 You have no plans or intentions that may materially alter the carrying value and where relevant the fair value measurements or classification of assets and liabilities reflected in the financial statements.

• 4 You have disclosed all known actual or possible litigation and claims whose effects should be considered when preparing the financial statements and these have been disclosed in accordance with the requirements of accounting standards.

• 5 Related party relationships and transactions have been appropriately accounted for and disclosed in accordance with the requirements of accounting standards (see Appendix).

Armstrong Watson LLP First Floor One Strawberry Lane Newcastle upon Tyne NE1 4BX T: 0191 434 0830

www.armstrongwatson.co.uk www.armstrongwatsonfp.co.uk

Armstrong Watson LLP is a limited liability partnership registered in England and Wales, number OC415608. The registered office is James Watson House, Montgomery Way, Rosehill, Carlisle, CA1 2UU where a list of members is kept. Armstrong Watson LLP is regulated by the Institute of Chartered Accountants in England and Wales for a range of investment business activities. Unless otherwise indicated, either expressly or by the context, we use the word “partner” to describe a member of Armstrong Watson LLP or an employee of Armstrong Watson LLP in their capacity as such. Armstrong Watson Audit Limited is registered to carry on audit work in the UK by the Institute of Chartered Accountants in England and Wales. Registered as a limited company in England and Wales, number 8800970. The registered office is James Watson House, Montgomery Way, Rosehill, Carlisle, CA1 2UU. Armstrong Watson Audit is a trading style of Armstrong Watson Audit Limited. Armstrong Watson Financial Planning Limited is authorised and regulated by the Financial Conduct Authority. Firm reference number 542122. Registered as a limited company in England and Wales, number 7208672. The registered office is James Watson House, Montgomery Way, Rosehill, Carlisle, CA1 2UU. Armstrong Watson Financial Planning & Wealth Management is a trading style of Armstrong Watson Financial Planning Limited.

Armstrong Watson Trustees Limited is a limited company registered in England and Wales, number 8449 5656. The registered office is James Watson House, Montgomery Way, Rosehill, Carlisle, CA1 2UU. MyRetirement is a trading style of Armstrong Watson Financial Planning Limited.

Armstrong Watson is a trading style of Armstrong Watson LLP, Armstrong Watson Audit Limited and Armstrong Watson Financial Planning Limited.

• 6 All events since the balance sheet date which require disclosure or which would materially affect the amounts in the financial statements have been adjusted or disclosed in the financial statements.

• 7 You confirm that the financial statements are free from material misstatements, including omissions. You believe that those uncorrected misstatements identified during the preparation of the financial statements are immaterial both individually and in aggregate to the financial statements as a whole.

• 8 You confirm that, having considered your expectations and intentions for the next twelve months, and the availability of working capital, the Society is a going concern. You confirm that the disclosures in the accounting policies are an accurate reflection of the reasons for your consideration that the financial statements should be drawn up on a going concern basis.

Information provided

• 9 All accounting records and relevant information have been made available to us for the purpose of our preparation of the financial statements. You have provided to us all other information requested and given unrestricted access to persons within the Society from whom we have deemed it necessary to request information.

• 10 All transactions undertaken by the Society have been properly reflected in the accounting records and are reflected in the financial statements.

• 11 You confirm that you are not aware of any possible or actual instance of non-compliance with those laws and regulations which provide a legal framework within which the Society conducts its business and which could affect the financial statements. The Society has complied with all aspects of contractual agreements that could have a material effect on the financial statements in the event of non-compliance.

• 12 You confirm that you have disclosed to us the identity of the Society’s related parties and all related party relationships and transactions relevant to the company that you are aware of.

• 13 The Society has satisfactory title to all assets, and there are no liens or encumbrances on the assets except for those disclosed in the financial statements.

• 14 There are no liabilities, contingent liabilities or guarantees to third parties other than those disclosed in the financial statements.

• 15 You confirm that where the receipt of grants and donations are subject to specific terms or conditions notified to you, there have been no breaches of those terms or conditions during the year in the application of such income.

• 16 The Society has at no time during the year entered into any arrangement, transaction or agreement to provide credit facilities (including loans, quasi-loans or credit transactions) for Council members, nor to guarantee or provide security for such matters, except as disclosed in the financial statements.

• 17 You acknowledge your responsibility regarding disclosure of information to us and confirm that:

• so far as each Council member is aware, there is no relevant information of which we are unaware: and

• each Council member has taken all the steps that they ought to have taken as a Council member to make themselves aware of any relevant information and to establish that you are aware of that information.

• 18 You confirm the following specific representations made to us during the course of our work:

• the calculations of recharges of staff costs to BBTS Enterprises Limited are based upon estimated time spent on each activity by each staff member.

• office overheads recharged to and from BBTS Enterprises Limited are based upon estimated use of those resources by each activity.

You confirm to the best of your knowledge and belief that the above representations are made on the basis of enquiries of management and staff with relevant knowledge and experience and, where appropriate, of inspection of supporting documentation sufficient to satisfy ourselves that you can properly make each of the above representations to us.

We should be grateful if you would kindly acknowledge your agreement with this letter by signing the duplicate where indicated and returning it to us.

Yours faithfully

Armstrong Watson LLP

We confirm that we have read and understood the contents of this letter and agree that it accurately reflects the representations made to you by the directors during the course of preparing the company’s accounts.

Signed on behalf of the British Blood Transfusion Society by:

PROF DAVID ROBERTS

PROF DAVID ROBERTS (Dec 1, 2025 11:47:41 GMT) ~~……………………………………………………………~~ ………. Dr D Roberts

01/12/2025

…………………………………………………………………….. (Date)

APPENDIX

Client British Blood Transfusion Society Period End 31 March 2025

==> picture [436 x 85] intentionally omitted <==

----- Start of picture text -----
Party Relationship Nature of transaction
Dr G D Poole Council member Expenses claimed £379
Miss J Staves Council member Expenses claimed £1,266
Dr N Osaro Council member Expenses claimed £85
Miss C George Council member Expenses claimed £294
Dr D Roberts Council member Expenses claimed £150
Mr D Gaskin Council member Expenses claimed £212
----- End of picture text -----

The British Blood Transfusion Society Accounts 2025

Final Audit Report

2025-12-03

Created: 2025-10-23 By: Glenn Edmonds ([e-mail]) Status: Signed Transaction ID: CBJCHBCAABAANm2YT2kW2v7BriN3ft1JjoTe-duDHZUM

"The British Blood Transfusion Society Accounts 2025" History

Document created by Glenn Edmonds ([e-mail])

2025-10-23 - 14:46:41 GMT- IP address: 62.89.150.154

Document emailed to [e-mail] for signature

2025-10-23 - 14:49:35 GMT

Email viewed by [e-mail]

2025-10-24 - 11:37:29 GMT- IP address: 80.47.0.56

New document URL requested by [e-mail]

2025-11-29 - 17:04:49 GMT- IP address: 89.241.163.229

• Email viewed by [e-mail]

2025-11-29 - 17:05:07 GMT- IP address: 104.47.85.126

• Signer [e-mail] entered name at signing as R Haggas

2025-11-29 - 17:05:51 GMT- IP address: 89.241.163.229

Document e-signed by R Haggas ([e-mail])

Signature Date: 2025-11-29 - 17:05:53 GMT - Time Source: server- IP address: 89.241.163.229

Document emailed to [e-mail] for signature

2025-11-29 - 17:05:54 GMT

Email viewed by [e-mail]

2025-12-01 - 11:47:04 GMT- IP address: 104.47.11.254

Signer [e-mail] entered name at signing as PROF DAVID ROBERTS

2025-12-01 - 11:47:39 GMT- IP address: 5.68.149.138

• Document e-signed by PROF DAVID ROBERTS ([e-mail]) Signature Date: 2025-12-01 - 11:47:41 GMT - Time Source: server- IP address: 5.68.149.138 Document emailed to David Gold ([e-mail]) for signature 2025-12-01 - 11:47:43 GMT

• Email viewed by David Gold ([e-mail]) 2025-12-01 - 11:47:50 GMT- IP address: 172.186.8.134

• Signer David Gold ([e-mail]) entered name at signing as D R Gold 2025-12-03 - 08:38:13 GMT- IP address: 62.89.150.154

• Document e-signed by D R Gold ([e-mail]) Signature Date: 2025-12-03 - 08:38:15 GMT - Time Source: server- IP address: 62.89.150.154

• Agreement completed.

2025-12-03 - 08:38:15 GMT